April 23, 2026

Biocon Limited

Raj01 mins



Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled “Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars”. |SUBJECT: Press Release



Source link

Raj
Author: Raj

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News